Regulation of differentiation by HBP1, a target of the retinoblastoma protein

Molecular and Cellular Biology

Volumn 18, Issue 8, 1998, Pages 4732-4743

  Shih, Heather H ^a   Tevosian, Sergei G ^a,b   Yee, Amy S ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH INHIBITOR; MYOD PROTEIN; MYOGENIN; PROTEIN HBP1; PROTEIN P130; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 0031876217     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.8.4732     Document Type: Article

References (59)

1. Barone, M. V., A. Crozat, A. Tabaee, L. Philipson, and D. Ron. 1994. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev. 8:453-464.
2. Batchvarova, N., X. Z. Wang, and D. Ron. 1995. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J. 14:4654-4661.
3. Braun, T., M. Rudnicki, H.-H. Arnold, and R. Jaenisch. 1992. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 71:369-382.
4. Chen, P. L., D. J. Riley, Y. Chen, and W. H. Lee. 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10:2794-2804.
5. Cheng, T. C., B. S. Tseng, J. P. Merlie, W. H. Klein, and E. N. Olson. 1995 Activation of the myogenin promoter during mouse embryogenesis in the absence of positive autoregulation. Proc. Natl. Acad. Sci. USA 92:561-565.
6. Classon, M., C. Gorka, B. K. Kennedy, N. Dyson, and E. Harlow. Opposing roles for pRB and p107/p130 in adipocyte differentiation. Submitted for publication.
7. Cobrinik, D., P. Whyte, D. Peeper, T. Jacks, and R. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392-2404.
8. Corbeil, H., P. Whyte, and P. E. Branton. 1995. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene 11:909-920.
9. Cress, W. D., and J. R. Nevins. 1996. Use of the E2F transcription factor by DNA tumor virus regulatory proteins, p. 63-78. In P. J. Farnham (ed.), Transcriptional control of cell growth: the E2F gene family, vol. 208. Springer-Verlag, New York, N.Y.
10. Datta, B., W. Min, S. Burma, and P. Lengyel. 1998. Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity of p202. Mol. Cell. Biol. 18:1074-1083.
11. Farnham, P. J. 1996. Transcriptional control of cell growth; the E2F family, vol. 208. Springer-Verlag, New York, N.Y.
12. Fiddler, T. A., L. Smith, S. J. Tapscott, and M. J. Thayer. 1996. Amplification of MDM2 inhibits MyoD-mediated myogenesis. Mol. Cell. Biol. 16:5048-5057.
13. Grosschedl, R. 1995. Higher order nucleoprotein complexes in transcription: analogies with site-specific recombination. Curr. Opin. Cell Biol. 7:362-370.
14. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
15. Hunter, T. 1997. Oncoprotein networks. Cell 88:333-346.
16. Hurford, R. K., D. Cobrinik, M.-H. Lee, and N. Dyson. 1997. pRb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1447-1463.
17. Ikeda, M. A., L. Jakoi, and J. R. Nevins. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93:3215-3220.
18. Lassar, A., M. Thayer, R. Overell, and H. Weintraub. 1989. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 58:659-667.
19. Lavender, P., L. Vandel, A. J. Bannister, and T. Kouzarides. 1997. The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene 14:2721-2728.
20. Lazaro, J. B., M. Kitzmann, M. A. Poul, M. Vandromme, N. J. Lamb, and A. Fernandez. 1997. Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J. Cell Sci. 110:1251-1260.
21. + transport-defective yeast and regulation of HBP1, a new putative HMG transcriptional regulator. Nucleic Acids Res. 22:3685-3688.
22. Maione, R., and P. Amati. 1997. Interdependence between muscle differentiation and cell-cycle control. Biochim. Biophys. Acta 1332:M19-M30.
23. Maione, R., G. Fimia, P. Holman, B. Schaffhausen, and P. Amati. 1994. Retinoblastoma antioncogene is involved in the inhibition of myogenesis by polyomavirus large T antigen. Cell Growth Differ. 5:231-237.
24. Maroto, M., R. Reshef, E. Munsterberger, S. Koester, M. Goulding, and A. B. Lassar. 1997. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 89:139-148.
25. Moberg, K., M. A. Starz, and J. A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436-1449.
26. Molkentin, J. D., and E. N. Olson. 1996. Defining the regulatory networks for muscle development. Curr. Opin. Genet. Dev. 6:445-453.
27. Molkentin, J. D., and E. N. Olson. 1996. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 93:9366-9373.
28. Mulligan, G. J., J. Wong, and T. Jacks. 1998. p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol. Cell. Biol. 18:206-220.
29. Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L. Y. Jan, Y. N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, A. B. Lassar, H. Weintraub, and D. Baltimore. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
30. Novitch, B. G., G. J. Mulligan, T. Jacks, and A. B. Lassar. 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135:441-456.
31. Nusse, R. 1997. A versatile transcriptional effector of wingless signaling. Cell 89:321-323.
32. Olson, E. N., and W. H. Klein. 1994. bHLH factors in muscle development: deadlines and commitments, what to leave in and what to leave out. Genes Dev. 8:1-8.
33. Olson, E. N., G. Spizz, and M. Tainsky. 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7:2104-2111.
34. Phillipot, A., E. Porro, M. W. Kirschner, and L.-H. Tsai. 1997. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev. 11:1409-1421.
35. Rao, S., C. Chu, and S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix proteins. Mol. Cell. Biol. 14:5259-5267.
36. Rawls, A., and E. N. Olson. 1997. MyoD meets its maker. Cell 89:5-8.
37. Riley, D. J., C. Y. Liu, and W. H. Lee. 1997. Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression. Mol. Cell. Biol. 17:7342-7352.
38. Ron, D., and J. F. Habener. 1992. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6:439-453.
39. Rudnicki, M., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71:383-390.
40. Rudnicki, M., T. Braun, S. Hinuma, and R. Jaenisch. 1993. MyoD or Myf 5 is required for formation of skeletal muscle. Cell 75:1351-1359.
41. -/- muscle cells. Science 264:1467-1470.
42. Sellers, W. R., B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, and W. G. J. Kaelin. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12:95-106.
43. 42a. Sheppard, K. A., and A. S. Yee. Unpublished observations.
44. Shin, E., A. Shin, C. Paulding, B. Schaffhausen, and A. S. Yee. 1995. Multiple changes in E2F transcription factor function occur upon muscle differentiation. Mol. Cell. Biol. 15:2252-2262.
45. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblast by cyclin D1-dependent kinase. Science 267:1022-1023.
46. 1 cell state. Mol. Cell. Biol. 16:6965-6976.
47. Sternberg, E. A., G. Spizz, M. W. Perry, D. Vizard, T. Weil, and E. N. Olson. 1988. Identification of upstream and intragenic regulatory elements that confer cell type-restricted and differentiation-specific expression on the muscle creatine kinase gene. Mol. Cell. Biol. 8:2896-2909.
48. Tajbakhsh, S., D. Rocancourt, G. Cossu, and M. Buckingham. 1997. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89:127-138.
49. 47a. Tevosian, S. Unpublished data.
50. Tevosian, S., K. E. Paulson, R. Bronson, and A. S. Yee. 1996. Expression of the E2F-1/DP-1 transcription factor during murine development. Cell Growth Differ. 7:43-52.
51. Tevosian, S. G., H. Shih, K. G. Mendelson, K. A. Sheppard, K. E. Paulson, and A. S. Yee. 1997. HBP1: an HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev. 11:383-396.
52. Thayer, M. J., S. J. Tapscott, R. L. Davis, W. Wright, A. B. Lassar, and H. Weintraub. 1989. Positive auto-regulation of the myogenic determination gene MyoD1. Cell 58:241-248.
53. Weintraub, H., R. Davis, D. Lockshon, and A. Lassar. 1990. MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. USA 87:5623-5627.
54. Yee, A. S., P. Raychaudhuri, L. Jakoi, and J. R. Nevins. 1989. The adenovirus-inducible factor E2F stimulates transcription following specific DNA binding. Mol. Cell. Biol. 9:578-585.
55. Yee, A. S., H. S. Shih, and S. G. Tevosian. 1998. New perspectives on retinoblastoma family functions in differentiation. Front. Biosci., in press.
56. Yee, S. P., and P. W. Rigby. 1993. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 7:1277-1289.
57. Yeh, W. C., Z. Cao, M. Classon, and S. L. McKnight. 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9:168-181.
58. Zackenhaus, E., Z. Jiang, D. Chung, J. D. Marth, R. A. Phillips, and B. L. Gallie. 1996. pRB controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10: 3051-3064.
59. Zingg, J. M., G. Pedrazza-Alva, and J. P. Jost. 1994. MyoD1 promoter autoregulation is mediated by two proximal E-boxes. Nucleic Acids Res. 22: 2234-2241.